Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_assertion type Assertion NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_head.
- NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_assertion description "[MMP-2, MMP-9, MT1-MMP and TIMP-2 are valid markers of poor survival in advanced-stage ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_provenance.
- NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_assertion evidence source_evidence_literature NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_provenance.
- NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_assertion SIO_000772 11988310 NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_provenance.
- NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_assertion wasDerivedFrom befree-20140225 NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_provenance.
- NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_assertion wasGeneratedBy ECO_0000203 NP718588.RApxL2QT0Vn5Mu4GV3O-CiDL9EHZ-xjU9Z01Hs09IltQA130_provenance.